Home
>
National Drug Code (NDC)
>
Piperacillin, Tazobactam
Piperacillin, Tazobactam - 25021-165-30 - (Piperacillin Sodium, Tazobactam Sodium)
Drug Information of Piperacillin, Tazobactam
| Product NDC: | 25021-165 |
| Proprietary Name: | Piperacillin, Tazobactam |
| Non Proprietary Name: | Piperacillin Sodium, Tazobactam Sodium |
| Active Ingredient(s): | 3; .375 g/15mL; g/15mL & nbsp; Piperacillin Sodium, Tazobactam Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Piperacillin, Tazobactam
| Product NDC: | 25021-165 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065498 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110616 |
Package Information of Piperacillin, Tazobactam
| Package NDC: | 25021-165-30 |
| Package Description: | 10 VIAL in 1 CARTON (25021-165-30) > 15 mL in 1 VIAL |
NDC Information of Piperacillin, Tazobactam
| NDC Code | 25021-165-30 |
| Proprietary Name | Piperacillin, Tazobactam |
| Package Description | 10 VIAL in 1 CARTON (25021-165-30) > 15 mL in 1 VIAL |
| Product NDC | 25021-165 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piperacillin Sodium, Tazobactam Sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110616 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 3; .375 |
| Strength Unit | g/15mL; g/15mL |
| Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
